The Ascletis boss wants the biotech start-up to develop its own world-class drugs
Related Posts
Isolating Israel
China's CEOs Regain Short-Term Confidence
City gets China's first electric car rental outlet
China Mobile Hong Kong launches IDC Service
Winners and losers in China’s next decade
Delay only makes climate action more urgent
IDG, DCM, Northern Light Invest $100M In FXiaoKe
GPS data reveal secretive Chinese research vessels crossing Pacific
China property: accelerating meltdown threatens other markets
China's Fortune Fountain Capital To Acquire French Luxury Crystal Retailer Baccarat